Palliative Medicine is a premier journal dedicated to advancing the field of palliative care, published by SAGE Publications Ltd. Established in 1987 and continuing through 2024, this esteemed journal focuses on the integration of pain management and comprehensive care for patients with life-limiting illnesses. With its impressive impact factor and a prestigious Q1 ranking in both Anesthesiology and Pain Medicine, as well as in Medicine (miscellaneous), it stands as a critical resource for researchers, healthcare professionals, and students engaged in this vital area of medicine. The journal emphasizes original research, reviews, and clinical studies that contribute to the understanding and practice of palliative care, promoting improved quality of life and support for patients and their families. Although not open access, articles are accessible through institutional subscriptions, ensuring the dissemination of knowledge to a wide audience. Whether you are a seasoned researcher or an emerging professional in the field, Palliative Medicine remains an invaluable platform for scholarly exchange and innovation.

JOURNAL OF PALLIATIVE CARE is a premier publication in the field dedicated to advancing the understanding and practice of palliative care. Published by SAGE Publications Inc, this journal serves as a vital platform for researchers, healthcare professionals, and students who are at the forefront of improving patient quality of life across various medical contexts. Since its inception, the journal has provided a rich repository of interdisciplinary research and insightful articles, addressing essential topics such as pain management, end-of-life care, and psychological support. With a respectable impact factor and a Q3 quartile ranking in the miscellaneous medicine category, it reflects the growing importance of palliative care in contemporary healthcare. The journal covers pivotal research from 1985 to 2015 and 2017 to 2024, underscoring its commitment to fostering a well-rounded discourse within the medical community. Researchers seeking to contribute to the field will find this journal an invaluable resource for disseminating cutting-edge findings and practical applications.

Onkologija is a distinguished open-access journal dedicated to the field of oncology, published by the Institute of Oncology Ljubljana. With its ISSN 1408-1741 and E-ISSN 1581-3215, this journal has become a crucial platform for researchers and healthcare professionals since its transition to open-access in 2008, allowing widespread dissemination of critical findings and innovations in cancer research and treatment. Located in Ljubljana, Slovenia, the journal aims to bridge the gap between clinical practice and research by publishing high-quality original articles, reviews, and case studies that address pivotal issues in oncology. Although specific metrics such as HIndex and Scopus ranks are currently unavailable, Onkologija’s commitment to advancing oncology knowledge is evident in its engaging publications that attract a diverse readership, making it an essential resource for anyone invested in the battle against cancer.

Current Oncology Reports is a prestigious academic journal dedicated to the field of oncology, published by Springer and based in the United States. With an impressive impact factor and ranking as a Q1 journal in the 2023 category of Oncology, it positions itself among the top-tier publications within the discipline. Established in 1999, the journal has been a vital resource for researchers, professionals, and students alike, providing comprehensive insights and the latest advancements in cancer research and treatment. Through its rigorous peer-review process, Current Oncology Reports disseminates high-quality original articles, reviews, and clinical studies that foster collaboration and innovation in the oncology community. Although it currently operates under a subscription model, the journal remains committed to accessibility, ensuring that critical findings reach a broad audience. As such, it serves as an essential platform for those dedicated to the fight against cancer, making significant contributions to the evolving landscape of oncology.

International Journal of Palliative Nursing is a renowned peer-reviewed journal dedicated to advancing the field of palliative care and nursing. Published by MA HEALTHCARE LTD in the United Kingdom, this journal has been a pivotal resource for healthcare professionals, researchers, and students alike since its inception in 2000. With an ISSN of 1357-6321, it is well-regarded for its commitment to high-quality research and practical insights, maintaining a Q3 category ranking in Advanced and Specialized Nursing. Despite its non-open access format, the journal offers a wealth of knowledge through a diverse array of articles that cover the latest advancements and best practices in palliative nursing. Its Scopus Rank at #36/63 reflects its respectable standing in the nursing community and highlights its contributions to the interdisciplinary realm of palliative care. The journal is an invaluable platform for fostering dialogue and sharing innovative approaches to nurture compassionate patient care.

Journal of Cancer Policy is an esteemed publication devoted to the critical intersection of health policy and oncology. Published by Elsevier Sci Ltd in the United Kingdom, this journal has been a pivotal platform since its inception in 2013, contributing to the field's discourse on cancer management and policy-making strategies. With an impressive Q2 ranking in both the Health Policy and Oncology categories for 2023, it underscores its significance in shaping policy frameworks that address the complexities of cancer care. The journal is listed in Scopus with a respectable rank of #177 in Health Policy and #261 in Oncology, indicating its broad reach and impactful contributions to research and scholarly discussions. While the journal operates under a subscription model, it aims to provide readers with high-quality research that can influence health decisions and policy formation. As a vital resource for researchers, healthcare professionals, and students alike, the Journal of Cancer Policy plays a fundamental role in advancing the understanding of how policies can improve cancer outcomes and healthcare systems.

JNCI Cancer Spectrum, published by Oxford University Press, is a leading open-access journal dedicated to advancing the field of cancer research and oncology. With an impressive impact demonstrated through its Q1 ranking in both Cancer Research and Oncology categories for 2023, this journal provides a vital platform for disseminating high-quality research and innovative findings in a rapidly evolving landscape. Since its inception in 2017, JNCI Cancer Spectrum has embraced open access, enhancing the accessibility of evidence-based knowledge to researchers, professionals, and students across the globe. Additionally, it boasts notable positions in Scopus rankings, with a strong performance in both the Medicine and Biochemistry, Genetics and Molecular Biology categories. The journal is committed to its objectives of fostering collaborative efforts and encouraging dialogue among experts, making it an essential resource for anyone involved in cancer research.

Lung Cancer Management, published by FUTURE MEDICINE LTD, is a premier academic journal dedicated to the evolving field of oncology and respiratory medicine. With an ISSN of 1758-1966 and an E-ISSN of 1758-1974, this journal offers a platform for the dissemination of cutting-edge research, clinical studies, and expert reviews, all focusing on the latest advances in lung cancer treatment and management. Despite being a relatively new entry since its inception in 2014 and achieving its converged years from 2020 to 2024, it has already established itself in the Q3 quartile for both oncology and pulmonary and respiratory medicine as of 2023, according to category quartiles rankings. With a Scopus ranking of #98 in the category of Pulmonary and Respiratory Medicine and #266 in Oncology, the journal reflects a commitment to quality and relevance in its content. Although it does not offer open access, it remains a crucial resource for researchers, clinicians, and students seeking to stay informed about the latest developments and practical approaches in lung cancer management. The journal is accessible from its base in the United Kingdom, at UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ensuring that it caters to a global audience eager to explore and contribute to this vital field of medicine.

JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, published by Taylor & Francis Inc, is a vital resource for professionals in the fields of anesthesiology, pain medicine, and pharmacology. With an ISSN of 1536-0288 and an E-ISSN of 1536-0539, this esteemed journal has been providing a platform for innovative research and critical reviews since its inception in 2002, and it will continue to contribute to scientific discourse until 2024. Holding a Q2 ranking in Anesthesiology and Pain Medicine and a Q3 ranking in Medical Pharmacology, the journal is positioned to deliver high-impact articles that explore advancements in pain management and palliative care strategies. While not an Open Access journal, it offers significant subscription-based access to its curated content, ensuring that researchers and practitioners have the opportunity to stay updated on the latest trends and findings in pain therapy. Furthermore, with its Scopus rankings reflecting ongoing relevance and a robust academic community, this journal is essential for those aiming to deepen their understanding of pain management pharmacotherapy.

Welcome to the Journal of Palliative Medicine, a distinguished peer-reviewed publication dedicated to advancing the field of palliative care. Published by Mary Ann Liebert, Inc., this journal serves as a vital resource for researchers, healthcare professionals, and students in the disciplines of anesthesiology, nursing, and general medicine. With an impressive track record since its inception in 1998, the journal has achieved Q1 status in both Anesthesiology and Pain Medicine, as well as in Nursing (Miscellaneous), reflecting its scholarly impact within the academic community. The impact factor and rank underscore its significance, with the journal positioned at the 75th percentile in General Nursing and the 65th percentile in Anesthesiology and Pain Medicine according to Scopus rankings. Though the journal follows a subscription model, it remains committed to disseminating critical research that improves patient care and quality of life for those facing serious illnesses. As the field continues to evolve, the Journal of Palliative Medicine remains a cornerstone for fostering innovation and education in palliative practices, underscoring the importance of compassionate care.